# Ultra-low-dose CACS in a Large Population

> **NCT03637231** · NA · TERMINATED · sponsor: **University of Zurich** · enrollment: 301 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DIAGNOSTIC_TEST:** Ultra low-dose CTAC

## Key facts

- **NCT ID:** NCT03637231
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-05
- **Primary completion:** 2021-10-25
- **Final completion:** 2021-10-25
- **Target enrollment:** 301 (ACTUAL)
- **Why stopped:** The preliminary findings render it very unlikely that the methodology can be refined further in order to yield more accurate results even if more patients would be included and the study would be continued.
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03637231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03637231, "Ultra-low-dose CACS in a Large Population". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03637231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*